Pharming Group Q4 Earnings Call Highlights

Bron: Yahoo Entertainment

Gepubliceerd op: 2026-03-12

Samsung adds free repairs and more to its smartphone subscription plan

Bron: SamMobile

Autheur: Asif Iqbal Shaik

Gepubliceerd op: 2026-02-23

Samsung introduced a smartphone subscription service in South Korea last year, and it quickly gained traction among buyers of its high-end devices. Ahead of the launch of the Galaxy S26 series, the company is upgrading the program with more benefits, includin…

Pharming Group to report fourth quarter and full year 2025 financial results and provide business update on March 12

Bron: GlobeNewswire

Autheur: Pharming Group N.V.

Gepubliceerd op: 2026-02-26

Pharming to report 4th quarter full year 2025 financial results & provide a business update on March 12, 2026 & host conference call 13:30 CET/08:30 EDT….

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. – PHAR

Bron: GlobeNewswire

Autheur: Pomerantz LLP

Gepubliceerd op: 2026-02-24

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Pharming Group N.V. (“Pharming” or the “Company”) (NASDAQ: PHAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-…

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. – PHAR

Bron: GlobeNewswire

Autheur: Pomerantz LLP

Gepubliceerd op: 2026-03-03

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Pharming Group N.V. (“Pharming” or the “Company”) (NASDAQ: PHAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646…

Pharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow

Bron: GlobeNewswire

Autheur: Pharming Group N.V.

Gepubliceerd op: 2026-03-12

Pharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow…

B-cell Inhibitors Market for Non-Oncology Diseases, 2026-2035 Industry Trends and Global Forecasts – Growing Prevalence of Autoimmune Disorders and Hematologic Cancers Drives Rapid Advancement

Bron: GlobeNewswire

Autheur: Research and Markets

Gepubliceerd op: 2026-03-12

Key opportunities in the B-cell inhibitors market for non-oncology diseases include the rising demand for targeted immunomodulatory therapies, driven by increasing autoimmune disorder prevalence. Strategic partnerships and innovation efforts focus on overcomi…

Pharmaceutical and Biotechnology Royalty Rates Agreements Report and Directory 2026: Insights Into 1,567 Licensing Transactions by Company A-Z, Therapeutic Area, Technology, Headline Value

Bron: GlobeNewswire

Autheur: Research and Markets

Gepubliceerd op: 2026-03-12

This report is tailored for C-level executives, business development professionals, licensing managers, legal advisors, and anyone involved in pharmaceutical and biotechnology deal-making. It provides the tools needed to evaluate and negotiate royalty terms e…